Literature DB >> 17005747

Influence of disk separation distance on accuracy of the disk approximation test for detection of inducible clindamycin resistance in Staphylococcus spp.

Matthew V N O'Sullivan1, Yongwei Cai, Fanrong Kong, Xianyu Zeng, Gwendolyn L Gilbert.   

Abstract

We undertook this study to assess the accuracy of the clindamycin-erythromycin disk approximation test (D-test) for detection of inducible clindamycin resistance in Staphylococcus spp. One hundred sixty-three Staphylococcus aureus and 68 coagulase-negative Staphylococcus (CoNS) spp. which were erythromycin nonsusceptible but clindamycin susceptible were tested using the D-test performed at both 15-mm and 22-mm disk separations and compared with genotyping as the "gold standard." The rate of inducible clindamycin resistance was 96.3% for S. aureus and 33.8% for CoNS spp. The sensitivities of the D-tests performed at 15 mm and 22 mm were 100% and 87.7%, respectively, and specificities were 100% for both. The use of 22-mm disk separation for the D-test to detect inducible clindamycin resistance results in an unacceptably high very major error rate (12.3%). All isolates with false-negative results harbored the ermA gene, and the majority were methicillin-resistant Staphylococcus aureus. False-negative results were associated with smaller clindamycin zone sizes and double-edged zones. We recommend using a disk separation distance of </=15 mm. There is wide geographic variation in the rates of inducible clindamycin resistance, and each laboratory should determine the local rate before deciding whether to either perform the D-test routinely or else report that all erythromycin-resistant S. aureus isolates are also clindamycin resistant.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005747      PMCID: PMC1698332          DOI: 10.1128/JCM.01632-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

1.  Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci?

Authors:  S Panagea; J D Perry; F K Gould
Journal:  J Antimicrob Chemother       Date:  1999-10       Impact factor: 5.790

2.  Distribution of macrolide-resistance genes in Staphylococcus aureus blood-culture isolates from fifteen German university hospitals. M.A.R.S. Study Group. Multicentre Study on Antibiotic Resistance in Staphylococci.

Authors:  F J Schmitz; J Petridou; A C Fluit; U Hadding; G Peters; C von Eiff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-05       Impact factor: 3.267

3.  A preliminary in vitro study on inducible and constitutive clindamycin resistance in Staphylococcus aureus from a South Indian tertiary care hospital.

Authors:  Bangalore Viswanath Navaneeth
Journal:  Int J Infect Dis       Date:  2005-11-10       Impact factor: 3.623

4.  Inducible clindamycin resistance in clinical isolates of Staphylococcus aureus.

Authors:  Ravisekhar Gadepalli; Benu Dhawan; Srujana Mohanty; Arti Kapil; Bimal K Das; Rama Chaudhry
Journal:  Indian J Med Res       Date:  2006-04       Impact factor: 2.375

5.  Patterns of phenotypic resistance to the macrolide-lincosamide-ketolide-streptogramin group of antibiotics in staphylococci.

Authors:  J M Hamilton-Miller; S Shah
Journal:  J Antimicrob Chemother       Date:  2000-12       Impact factor: 5.790

6.  Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolates.

Authors:  Mukesh Patel; Ken B Waites; Stephen A Moser; Gretchen A Cloud; Craig J Hoesley
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

Review 7.  Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications.

Authors:  Roland Leclercq
Journal:  Clin Infect Dis       Date:  2002-01-11       Impact factor: 9.079

8.  Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance.

Authors:  D Drinkovic; E R Fuller; K P Shore; D J Holland; R Ellis-Pegler
Journal:  J Antimicrob Chemother       Date:  2001-08       Impact factor: 5.790

9.  Prevalence of resistance to macrolide, lincosamide and streptogramin antibiotics in Gram-positive cocci isolated in a Korean hospital.

Authors:  Jung-A Lim; Ae-Ran Kwon; Sook-Kyung Kim; Yunsop Chong; Kungwon Lee; Eung-Chil Choi
Journal:  J Antimicrob Chemother       Date:  2002-03       Impact factor: 5.790

10.  Induction of clindamycin resistance in erythromycin-resistant, clindamycin susceptible and methicillin-resistant clinical Staphylococcal isolates.

Authors:  Abdulrahman A Kader; Angamuthu Kumar; Ananth Krishna
Journal:  Saudi Med J       Date:  2005-12       Impact factor: 1.484

View more
  13 in total

1.  Rapid identification of methicillin-resistant Staphylococcus aureus transmission in hospitals by use of phage-derived open reading frame typing enhanced by multiplex PCR and reverse line blot assay.

Authors:  Matthew V N O'Sullivan; Fanrong Kong; Vitali Sintchenko; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

2.  Complete nucleotide sequence analysis of plasmids in strains of Staphylococcus aureus clone USA300 reveals a high level of identity among isolates with closely related core genome sequences.

Authors:  Adam D Kennedy; Stephen F Porcella; Craig Martens; Adeline R Whitney; Kevin R Braughton; Liang Chen; Carly T Craig; Fred C Tenover; Barry N Kreiswirth; James M Musser; Frank R DeLeo
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

3.  Genetic diversity of methicillin-resistant Staphylococcus aureus in a tertiary hospital in The Netherlands between 2002 and 2006.

Authors:  E Nulens; E E Stobberingh; E Smeets; H van Dessel; M A Welling; S Sebastian; F H van Tiel; P S Beisser; R H Deurenberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-01-08       Impact factor: 3.267

4.  Staphylococcus aureus carriage among GPs in The Netherlands.

Authors:  Michelle Ia Rijnders; Sita Nys; Christel Driessen; Christian Jpa Hoebe; Rogier M Hopstaken; Guy J Oudhuis; Arno Timmermans; Ellen E Stobberingh
Journal:  Br J Gen Pract       Date:  2010-12       Impact factor: 5.386

5.  Performance of an agar dilution method and a Vitek 2 card for detection of inducible clindamycin resistance in Staphylococcus spp.

Authors:  Christian Lavallée; Danielle Rouleau; Christiane Gaudreau; Michel Roger; Catherine Tsimiklis; Marie-Claude Locas; Simon Gagnon; Jocelyn Delorme; Annie-Claude Labbé
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

6.  Agar dilution method for detection of inducible clindamycin resistance in Staphylococcus spp.

Authors:  Clarence J Fernandes; Matthew V N O'Sullivan; Yongwei Cai; Fanrong Kong; Xianyu Zeng; Gwendolyn L Gilbert; George Kotsiou
Journal:  J Clin Microbiol       Date:  2007-10-17       Impact factor: 5.948

7.  Multiplex PCR and reverse line blot hybridization assay (mPCR/RLB).

Authors:  Matthew V N O'Sullivan; Fei Zhou; Vitali Sintchenko; Fanrong Kong; Gwendolyn L Gilbert
Journal:  J Vis Exp       Date:  2011-08-06       Impact factor: 1.355

8.  Incidence of constitutive and inducible clindamycin resistance among hospital-associated Staphylococcus aureus.

Authors:  B Sasirekha; M S Usha; J A Amruta; S Ankit; N Brinda; R Divya
Journal:  3 Biotech       Date:  2013-04-02       Impact factor: 2.406

9.  Cross-border dissemination of methicillin-resistant Staphylococcus aureus, Euregio Meuse-Rhin region.

Authors:  Ruud H Deurenberg; Eric Nulens; Havard Valvatne; Silvie Sebastian; Christel Driessen; Jos Craeghs; Els De Brauwer; Bernhard Heising; Yvette J Kraat; Joachim Riebe; Frans S Stals; Thera A Trienekens; Jacques Scheres; Alexander W Friedrich; Frank H van Tiel; Patrick S Beisser; Ellen E Stobberingh
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

10.  Epidemiological and Inducible Resistance in Coagulase Negative Staphylococci.

Authors:  Shadieh Abdollahi; Rashid Ramazanzadeh; Zahra Delami Khiabani; Enayat Kalantar
Journal:  Glob J Health Sci       Date:  2015-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.